Carefully manage the use of diuretics and RAAS blockers (e.g., ACE inhibitors, ARBs)
It addresses the most common side effects nausea, fatigue, GI distress, and electrolyte depletion through targeted ingredients: electrolytes with B6 for nausea and hydration, B-Complex for GI support, and protein with whey isolate and digestive enzymes for muscle preservation and comfortable digestion
For some individuals, the additional side effect burden at 12 mg is not worth that incremental improvement
After starting Mounjaro (tirzepatide, a dual GIP/GLP-1 receptor agonist), Holcombes A1C fell from nearly 7% to around 5.5%
doi: 10.1073/pnas.1514282112 54 RichterTACaicedoARoperSD
Risks and Considerations GLP-1 microdosing is an off-label practice